Printer Friendly

HEALTH DEVICES RESEARCH INSTITUTE (HDRI) APPOINTS DIGBY W. BARRIOS AND WILLIAM F. LALOR TO BOARD OF DIRECTORS

 REDWOOD CITY, Calif., Nov. 22 /PRNewswire/ -- Health Devices Research Institute (HDRI), an international epidemiologic and pharmacoeconomic research organization, today announced the appointments of Digby W. Barrios and William F. Lalor to the company's board of directors. Barrios and Lalor bring to HDRI more than sie?s of experience as leaders within the pharmaceutical industry.
 Barrios capped a 30-year career when he retired in 1992 after serving as the president and chief executive officer of Boehringer Ingelheim Corp., a leading pharmaceutical manufacturer. Under Barrios' four-year leadership, sales at Boehringer Ingelheim jumped from $400 million in 1987 to $625 million in 1992. He joined Boehringer Ingelheim in 1983 after a 21-year stint at E.R. Squibb & Sons. Barrios, 55, received his bachelor's of science in chemistry and biology from Loyola University.
 Lalor has also enjoyed a distinguished career in the pharmaceutical industry, retiring in 1991 after serving as the president of ICI Pharmaceuticals Group, a $1.2-billion company and a subsidiary of Imperial Chemical Industries (ICI), a diversified, global organization spanning several industries including chemicals, aerospace and pharmaceuticals.
 Lalor began his 41-year career with the Stuart Co. (Pasadena, Calif.) which was later acquired by ICI in 1971. Lalor holds a bachelor's of science degree from Montclair State College in New Jersey.
 Serving the worldwide pharmaceutical and medical device industries, HDRI specializes in epidemiologic and pharmacoeconomic studies of drugs and devices. HDRI services include the design and management of clinical trials, postmarket surveillance programs, adverse event investigations and other epidemiology-based programs. Headquartered in Redwood City, HDRI professionals include physicians, epidemiologists, pharmacoeconomists and others with international reputations as health care scientists. In August, the privately held company secured venture financing of more than $1.2 million.
 -0- 11/22/93
 /CONTACT: Robert W. Morgan, M.D., chairman and chief executive officer of Health Devices Research Institute, 415-595-4866/


CO: Health Devices Research Institute ST: California IN: MTC SU: PER

RB-TM -- SJ003 -- 6932 11/22/93 16:00 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 22, 1993
Words:323
Previous Article:USWA CANCELS NEWS CONFERENCE
Next Article:THE PILGRIMS SET SAIL ON THE MAYFLOWER ... FOR DALLAS
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters